These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6721984)

  • 1. Drug metabolite concentration-time profiles: influence of route of drug administration.
    Houston JB; Taylor G
    Br J Clin Pharmacol; 1984 Apr; 17(4):385-94. PubMed ID: 6721984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of plasma concentration-time curves after oral dosing.
    Ronfeld RA; Benet LZ
    J Pharm Sci; 1977 Feb; 66(2):178-80. PubMed ID: 839412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Route of administration and drug metabolism.
    Gibaldi M; Feldman S
    Eur J Pharmacol; 1972 Sep; 19(3):323-9. PubMed ID: 4640856
    [No Abstract]   [Full Text] [Related]  

  • 9. A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variations in drug elimination.
    Vaughan DP; Trainor A
    Br J Clin Pharmacol; 1975 Jun; 2(3):239-50. PubMed ID: 1234504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug metabolite kinetics.
    Houston JB
    Pharmacol Ther; 1981; 15(3):521-52. PubMed ID: 7048351
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.
    Cheng H; Shum L
    Biopharm Drug Dispos; 1993 Jan; 14(1):71-9. PubMed ID: 8427946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary, secondary, and tertiary metabolite kinetics.
    St-Pierre MV; Xu X; Pang KS
    J Pharmacokinet Biopharm; 1988 Oct; 16(5):493-527. PubMed ID: 3199316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M; Levy G
    JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat.
    Caccia S; Cappi M; Fracasso C; Garattini S
    Psychopharmacology (Berl); 1990; 100(4):509-14. PubMed ID: 2320712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of first-pass effect on availability of drugs on oral administration.
    Gibaldi M; Boyes RN; Feldman S
    J Pharm Sci; 1971 Sep; 60(9):1338-40. PubMed ID: 5567579
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of metabolite kinetics.
    Pang KS
    J Pharmacokinet Biopharm; 1985 Dec; 13(6):633-62. PubMed ID: 3914545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of first to zeroth moments of the plasma profile of an oral drug undergoing first-pass and linear reversible metabolism.
    Cheng H
    Biopharm Drug Dispos; 1995 Dec; 16(9):791-6. PubMed ID: 8580402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.